Drug Detail

Information about Istodax

Generic Name	Romidepsin
IND	FK228 or FR901228
Brand Name (US)	Istodax
Manufacturer	Gloucester Pharmaceuticals
Drug Type	HDAC inhibitor
Delivery	Intravenous
Approval Status	Approved for a non-GIST cancer
Indications	Cutaneous T cell lymphoma
Overall Strategy	GIST cell based
Strategy	Destroy KIT + Unblock cell death genes
Drug Category	HDAC inhibitor

Intravenous HDAC inhibitor approved in the US on Nov, 5th, 2010 for cutaneous T cell lymphoma. It is also sometimes referred to as depsipeptide.
For information related to Istoxax call 1-866-223-7145.